HH

https://xyonhealth.com/pages/dr-simon-pimstone

CEO at XYON Health
On the record
Represented by:
Share profile 
Link:
Bio
Edit

Dr. Simon Pimstone has over 25 years of experience in the life sciences, drug development and entrepreneurship. He brings this passion and expertise to his current role as CEO of XYON, an industry leading brand focused on developing sophisticated and effective solutions for hair loss.

He has held various management, board, and advisory roles at companies including Xenon Pharmaceuticals (Nasdaq: XENE), Eupraxia Pharmaceuticals (TSX: EPRX), Alpha9 Oncology and Kokua Pharmaceuticals.

In addition to these roles, Dr. Pimstone has served on the boards of several industry and healthcare associations. He was former chair of LifeSciences BC and the Providence Healthcare Research Trust, as well as being former vice-chair of BIOTECanada. He has also previously chaired the Canadian federal government State of Nation Report.

Dr. Pimstone serves as a Clinical Assistant Professor, Division of General Internal Medicine and Associate Member, Division of Cardiology, Department of Medicine, University of British Columbia.

He also serves as faculty on the Providence Health Care Heart and Lung Institute.

Outside of work, Dr. Pimstone enjoys playing soccer, hiking, surfing and cooking. His long term goal is to get involved in the delivery of services to improve mental healthcare in poor and marginalized communities.

Employment
Sign up to view all
  • Rosuvastatin and Hair Loss: Expert Insights from Cardiologist
    Dr. Pimstone explains that hair loss with statins is rare and reversible. He notes, "Hair loss cases are not common in clinical trials and may not be directly linked to the drug." Rosuvastatin and atorvastatin are frequently prescribed, possibly leading to more reported cases. He reassures that stopping the statin usually reverses hair loss within months.
  • Cardiologist Dr. Simon Pimstone Discusses Heart Health and Sexual Activity
    Dr. Pimstone advises that patients with coronary artery disease should cautiously build physical fitness to reduce cardiac event risks during sex. He notes, "Sexual activity can have significant benefits for heart health," equating it to moderate exercise. Consulting professionals for medication-related sexual issues is crucial for safety and well-being.
  • Cardiologist Warns: Oral Minoxidil May Pose Heart Risks
    Dr. Pimstone explains that oral minoxidil, a vasodilator, may cause hypotension and tachycardia. Those with coronary artery disease, heart failure, kidney impairment, or phaeochromocytoma should avoid it. If symptoms like dizziness, fainting, rapid heart rate, or chest pain occur, discontinue use and consult a doctor.
Headshots